|
|
| The Japanese Ministry of Health, Labour and Welfare (MHLW) has cleared Roche’s Avastin (bevacizumab) as a combination therapy and monotherapy to treat the aggressive form of brain cancer glioblastoma…
read all at
|
Japanese MHLW clears Roche’s Avastin as glioblastoma therapy
Uncategorized
Comments Off on Japanese MHLW clears Roche’s Avastin as glioblastoma therapy
Jun 212013